Primary Generalized Glucocorticoid Resistance And Hypersensitivity

    January 2011 in “ Hormone Research in Paediatrics
    Evangelia Charmandari
    New to Hydrocortisone? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This review discusses the molecular basis and clinical implications of primary generalized glucocorticoid resistance and hypersensitivity, attributing them to mutations in the human glucocorticoid receptor gene, and reports no new clinical findings.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document reviews the conditions of Primary Generalized Glucocorticoid Resistance (PGGR) and Primary Generalized Glucocorticoid Hypersensitivity (PGGH), which are caused by mutations or polymorphisms in the human glucocorticoid receptor (hGR) gene. These genetic alterations affect the body's sensitivity to glucocorticoids, leading to various clinical symptoms and influencing biological processes such as stress response, immune function, and metabolism. The review discusses molecular studies used for diagnosis, clinical manifestations, and treatment approaches, highlighting the importance of personalized dosing in glucocorticoid therapy due to interindividual variations in glucocorticoid sensitivity. The document does not provide specific numbers of people involved in studies, as it is a literature review summarizing expert knowledge up to May 2011.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results